Article info

Extended report
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab

Authors

  1. Correspondence to Dr Martin Neovius, Clinical Epidemiology Unit (T2), Department of Medicine (Solna), Karolinska Institutet, Stockholm SE-171 76, Sweden; martin.neovius{at}ki.se
View Full Text

Citation

Neovius M, Arkema EV, Olsson H for the ARTIS Study Group, et al
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab

Publication history

  • Received June 17, 2013
  • Revised August 25, 2013
  • Accepted November 3, 2013
  • First published November 27, 2013.
Online issue publication 
January 07, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

  • Lay summary

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.